ArticleScientific reports2021

Ruxolitinib early administration reduces acute GVHD after alternative donor hematopoietic stem cell transplantation in acute leukemia.

Binglei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.